当谨慎变成忽视:在帕金森病中深度大脑刺激和认知障碍
1Parkinson's Disease Research Clinic, Macquarie Medical School, Macquarie University, Sydney, Australia.
Journal of Parkinson's disease
|February 28, 2026
概括
深度大脑刺激可能有利于帕金森氏症患者的认知障碍,减少药物需求和改善生存率. 排除这些患者可能会导致更差的治疗结果和更多的住院治疗.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 老年学是一门学科.
背景情况:
- 从历史上看,显著的认知障碍被认为是帕金森病 (PD) 中深度大脑刺激 (DBS) 的禁忌.
- 从DBS研究中排除患有认知障碍的PD患者对该队列的潜在益处和风险的理解有限.
- 目前对晚期PD的药理管理,特别是对认知问题的药理管理,通常涉及具有显著副作用的复杂疗法.
研究的目的:
- 评估深度大脑刺激在帕金森病中对中度认知障碍患者的潜在益处和风险.
- 挑战关于认知障碍作为PD中DBS绝对禁忌的普遍临床教条.
- 探索DBS对这种患者群体的药物减少,生存和制度化的影响.
主要方法:
- 从中度认知障碍的PD患者中对DBS进行的小型研究中对新出现的证据的审查.
- 结果分析包括多巴胺疗法减少,非运动症状缓解,生存率和机构护理入院.
- 评估这一特定患者队列中手术和刺激相关并发症的发生率.
主要成果:
- 患有中度认知障碍的PD患者的深度大脑刺激可能允许显著减少多巴胺激素治疗,缓解非运动症状.
- 初步发现表明,DBS可能有利于这些患者的生存,并减少对这些患者的机构护理入院.
- 小规模研究没有显示PD患者的手术或刺激相关并发症显著增加中度认知障碍接受DBS.
结论:
- 从深度大脑刺激中排除可能会导致晚期帕金森病患者的潜在最佳结果认知障碍.
- 深度大脑刺激可能是选择中度认知障碍的PD患者的可行的治疗选择,需要进一步调查.
- 需要进行前性研究,以确定深度大脑刺激在中度认知障碍的帕金森病患者的疗效和安全性.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K


